Applegate Robert J, Sacrinty Matthew T, Kutcher Michael A, Baki Talal T, Gandhi Sanjay K, Santos Renato M, Kahl Frederic R, Little William C
Section of Cardiology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1045, USA.
J Invasive Cardiol. 2007 Apr;19(4):164-70.
To evaluate the adjusted risk of vascular complications after thrombin hemostasis patch-facilitated manual compression (THP-MC) for femoral artery access site management.
Thrombin hemostatic patches shorten time to hemostasis after cardiac procedures involving femoral artery access, but whether these patches are as safe as manual compression remains uncertain.
THP-MC (D-Stat Dry, Vascular Solutions, Minneapolis, Minnesota) was used in 3,464 consecutive patients including 2,464 diagnostic cardiac catheterizations (CATH) and 1,000 percutaneous coronary intervention procedures (PCI) performed via a femoral access at a single site (WFUBMC). A total of 4,371 procedures including 2,956 CATH and 1,415 PCI performed prior to use of THP-MC, and treated with manual compression, served as the control group. Ambulation was permitted 2 to 3 hours after THP-MC, and 3 to 8 hours after MC. Propensity to receive a THP was calculated, and adjusted in-hospital outcomes evaluated.
Time to hemostasis was similar for THP-MC (13.0 +/- 3.3 min) compared to MC (14.4 +/- 5.7 min), p = 0.51 for CATH, and was shorter for THP-MC (14.2 +/- 5.4 minutes) compared to MC (20.1 +/- 5.4 min), p <0.001, for PCI. Overall, the unadjusted incidence of any vascular complication (VC) was 0.6+/- for THP-MC and 1.0% for manual compression, p = 0.036. The propensity score-adjusted odds ratio for any VC comparing THP-MC to manual compression was 0.58 (0.34 to 0.99) for all procedures, 0.42 (0.20 to 0.87) for diagnostic procedures and 0.86 (0.39 to 1.88) for PCI.
In this large, single-center, contemporary observational study, use of THP-MC shortened manual compression time for PCI procedures, permitted early ambulation and was as safe as conventional manual compression.
评估凝血酶止血贴辅助手动压迫(THP-MC)用于股动脉穿刺部位处理后血管并发症的校正风险。
凝血酶止血贴可缩短涉及股动脉穿刺的心脏手术后的止血时间,但这些止血贴是否与手动压迫一样安全仍不确定。
在单一地点(WFUBMC)对3464例连续患者使用THP-MC(D-Stat Dry,Vascular Solutions,明尼阿波利斯,明尼苏达州),其中包括2464例诊断性心脏导管插入术(CATH)和1000例经股动脉途径进行的经皮冠状动脉介入治疗(PCI)。共有4371例手术,包括在使用THP-MC之前进行的2956例CATH和1415例PCI,并采用手动压迫治疗,作为对照组。THP-MC后2至3小时允许下床活动,手动压迫后3至8小时允许下床活动。计算接受THP的倾向,并评估校正后的院内结局。
与手动压迫(14.4±5.7分钟)相比,THP-MC的止血时间相似(13.0±3.3分钟),CATH的p = 0.51;与手动压迫(20.1±5.4分钟)相比,THP-MC的止血时间更短(14.2±5.4分钟),PCI的p<0.001。总体而言,THP-MC的任何血管并发症(VC)未校正发生率为0.6±,手动压迫为1.0%,p = 0.036。比较THP-MC与手动压迫的任何VC的倾向评分校正比值比在所有手术中为0.58(0.34至0.99),诊断性手术为0.42(0.20至0.87),PCI为0.86(0.39至1.88)。
在这项大型、单中心、当代观察性研究中,使用THP-MC缩短了PCI手术的手动压迫时间,允许早期下床活动,并且与传统手动压迫一样安全。